189 related articles for article (PubMed ID: 28282392)
1. Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier.
Desbordes P; Ruan S; Modzelewski R; Pineau P; Vauclin S; Gouel P; Michel P; Di Fiore F; Vera P; Gardin I
PLoS One; 2017; 12(3):e0173208. PubMed ID: 28282392
[TBL] [Abstract][Full Text] [Related]
2. Can pretreatment
Song H; Jiao Y; Wei W; Ren X; Shen C; Qiu Z; Yang Q; Wang Q; Luo QY
Eur Radiol; 2019 Jul; 29(7):3945-3954. PubMed ID: 30859285
[TBL] [Abstract][Full Text] [Related]
3. Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation.
Li Y; Zschaeck S; Lin Q; Chen S; Chen L; Wu H
Radiat Oncol; 2019 Feb; 14(1):35. PubMed ID: 30782182
[TBL] [Abstract][Full Text] [Related]
4. (18)F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer.
Jingu K; Kaneta T; Nemoto K; Takeda K; Ogawa Y; Ariga H; Koto M; Sakayauchi T; Takai Y; Takahashi S; Yamada S
Int J Clin Oncol; 2010 Apr; 15(2):184-90. PubMed ID: 20217449
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
[TBL] [Abstract][Full Text] [Related]
6. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
Pyka T; Bundschuh RA; Andratschke N; Mayer B; Specht HM; Papp L; Zsótér N; Essler M
Radiat Oncol; 2015 Apr; 10():100. PubMed ID: 25900186
[TBL] [Abstract][Full Text] [Related]
7. Early repeated 18F-FDG PET scans during neoadjuvant chemoradiation fail to predict histopathologic response or survival benefit in adenocarcinoma of the esophagus.
Malik V; Lucey JA; Duffy GJ; Wilson L; McNamara L; Keogan M; Gillham C; Reynolds JV
J Nucl Med; 2010 Dec; 51(12):1863-9. PubMed ID: 21078796
[TBL] [Abstract][Full Text] [Related]
8. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
Herrera FG; Breuneval T; Prior JO; Bourhis J; Ozsahin M
Radiat Oncol; 2016 Mar; 11():43. PubMed ID: 26984385
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of repeated F-18 FDG PET/CT parameters changes during preoperative chemoradiotherapy to predict pathologic response and overall survival in locally advanced esophageal adenocarcinoma patients.
Kim SJ; Koo PJ; Chang S
Cancer Chemother Pharmacol; 2016 Apr; 77(4):723-31. PubMed ID: 26891957
[TBL] [Abstract][Full Text] [Related]
10. Total Lesion Glycolysis Using ¹⁸F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer.
Hong JH; Kim HH; Han EJ; Byun JH; Jang HS; Choi EK; Kang JH; Yoo IeR
J Korean Med Sci; 2016 Jan; 31(1):39-46. PubMed ID: 26770036
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy.
Onal C; Torun N; Guler OC; Yildirim BA
Nucl Med Commun; 2016 Dec; 37(12):1282-1289. PubMed ID: 27612030
[TBL] [Abstract][Full Text] [Related]
12. Intratumor Textural Heterogeneity on Pretreatment (18)F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal Cancer.
Oh JS; Kang BC; Roh JL; Kim JS; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Aug; 22(8):2746-54. PubMed ID: 25487968
[TBL] [Abstract][Full Text] [Related]
13. Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.
Jayachandran P; Pai RK; Quon A; Graves E; Krakow TE; La T; Loo BW; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):471-7. PubMed ID: 22381904
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive values of interim
Han S; Kim YI; Woo S; Kim TH; Ryu JS
Ann Nucl Med; 2021 Apr; 35(4):447-457. PubMed ID: 33471289
[TBL] [Abstract][Full Text] [Related]
15. The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer.
van Rossum PS; Fried DV; Zhang L; Hofstetter WL; van Vulpen M; Meijer GJ; Court LE; Lin SH
J Nucl Med; 2016 May; 57(5):691-700. PubMed ID: 26795288
[TBL] [Abstract][Full Text] [Related]
16. Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer.
Larue RTHM; Klaassen R; Jochems A; Leijenaar RTH; Hulshof MCCM; van Berge Henegouwen MI; Schreurs WMJ; Sosef MN; van Elmpt W; van Laarhoven HWM; Lambin P
Acta Oncol; 2018 Nov; 57(11):1475-1481. PubMed ID: 30067421
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
Chang S; Kim SJ
Cancer Biother Radiopharm; 2016 Feb; 31(1):1-6. PubMed ID: 26844846
[TBL] [Abstract][Full Text] [Related]
18. Intratreatment Response Assessment With 18F-FDG PET: Correlation of Semiquantitative PET Features With Pathologic Response of Esophageal Cancer to Neoadjuvant Chemoradiotherapy.
Tandberg DJ; Cui Y; Rushing CN; Hong JC; Ackerson BG; Marin D; Zhang X; Czito BG; Willett CW; Palta M
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1002-1007. PubMed ID: 30055238
[TBL] [Abstract][Full Text] [Related]
19. Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer.
van Heijl M; Omloo JM; van Berge Henegouwen MI; Hoekstra OS; Boellaard R; Bossuyt PM; Busch OR; Tilanus HW; Hulshof MC; van der Gaast A; Nieuwenhuijzen GA; Bonenkamp HJ; Plukker JT; Cuesta MA; Ten Kate FJ; Pruim J; van Dekken H; Bergman JJ; Sloof GW; van Lanschot JJ
Ann Surg; 2011 Jan; 253(1):56-63. PubMed ID: 21233607
[TBL] [Abstract][Full Text] [Related]
20. Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy.
Seol YM; Kwon BR; Song MK; Choi YJ; Shin HJ; Chung JS; Cho GJ; Lee JC; Lee BJ; Wang SG; Kim HJ; Kim WT; Kim SJ; Yun EY
Acta Oncol; 2010; 49(2):201-8. PubMed ID: 20100156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]